| #433 |
Robert F. Jantz |
Rosemount |
3 |
| #433 |
Andre Pratama |
Western Digital Technologies |
3 |
| #433 |
Dheeraj Kumar Jain |
Microsoft |
3 |
| #433 |
Jeff Frazier |
— |
3 |
| #433 |
Stephen E. Sox |
RTX (Raytheon) |
3 |
| #433 |
Francis S Auricchio |
Mission Microwave Technologies |
3 |
| #433 |
Anthony Ian Lynas |
Sony |
3 |
| #433 |
Mark R. Kimball |
— |
3 |
| #433 |
John Reites |
— |
3 |
| #433 |
Jacqueline C. Chen |
Directv |
3 |
| #433 |
Russell Richard Niedwick |
— |
3 |
| #433 |
Robert Van Der Heyden |
Sri Sports Limited |
3 |
| #433 |
Michael Ragland |
Praedicat |
3 |
| #433 |
Szofia S. Bullain |
Children'S Medical Center |
3 |
| #433 |
Matthew James St. George |
Dioptics Medical Products |
3 |
| #433 |
Jeffrey C. Curie |
IBM |
3 |
| #433 |
Sowmya Soundar Rajan |
— |
3 |
| #433 |
Vit Ulinskas |
Novartis Ag |
3 |
| #433 |
Kim Dick Man |
— |
3 |
| #433 |
Sean Vassilaros |
— |
3 |
| #433 |
George D. Salapski |
The Boeing |
3 |
| #433 |
Ray Douglas Carpenter |
Quantumsphere |
3 |
| #433 |
John Gusiff |
Honda Motor Co. |
3 |
| #433 |
Eric J. Miramon |
Unknown |
3 |
| #433 |
Mohammed M. Mojarradi |
Caltech |
3 |
| #433 |
Michael J. Silka |
Children'S Hospital Los Angeles |
3 |
| #433 |
Robert A. Clay |
Frank'S International |
3 |
| #433 |
Deborah L. Robinson |
Caltech |
3 |
| #433 |
Kourosh Boutorabi |
Maxim Integrated Products |
3 |
| #433 |
Kent Policky |
Leach International |
3 |
| #433 |
Richard J. Fox |
— |
3 |
| #433 |
Chris Tyler |
— |
3 |
| #433 |
Lawrence C. Hopper |
Cytec Technology |
3 |
| #433 |
Till W. Liepmann |
— |
3 |
| #433 |
Peter R. Rose |
— |
3 |
| #433 |
Marco Holzner |
Entegris |
3 |
| #433 |
Allan K. Calvo |
Newport Fab |
3 |
| #433 |
Anthony Pipes |
Unknown |
3 |
| #433 |
John P. Burrell |
— |
3 |
| #433 |
Douglas T. Packard |
Alcon |
3 |
| #433 |
Brett Joseph Rogers |
Exemplis |
3 |
| #433 |
John D. Glover |
US Air Force |
3 |
| #433 |
Roy Shuman |
Fuerst Group |
3 |
| #433 |
Michelle Wong |
AbbVie |
3 |
| #433 |
Paul R. Nitza |
Emulex |
3 |
| #433 |
Roland Meissner |
— |
3 |
| #433 |
Iris Lee |
AbbVie |
3 |
| #433 |
Martin Kast |
Irx Therapeutics |
3 |
| #433 |
Bhushan Nagarajan |
Rivian Ip Holdings |
3 |
| #433 |
Kun Han Kim |
Masimo |
3 |